You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -237.4% | -3,072.2% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -3.2 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 10.5 | 138.2 |
| Price / Book value | 4.8 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 12,040.0% | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2016-03-31 | 0.03 | -12.85 | -38.95p | -8.4 | 0.0 | n/a | n/a | 0.0% |
| 2017-03-31 | 0.05 | -18.16 | -4,790.53p | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2018-03-31 | 0.04 | -20.97 | -54.23p | -1.5 | 0.0 | n/a | n/a | 0.0% |
| 2019-03-31 | 0.05 | -17.23 | -44.11p | -2.3 | 0.0 | n/a | n/a | 0.0% |
| 2020-03-31 | 6.07 | -13.86 | -34.96p | -2.8 | 0.0 | n/a | n/a | 0.0% |
| ReNeuron makes progress with hRPC therapy trial Sharecast News | 15 Jan |
|---|---|
| ReNeuron gets patent allowance in the US Sharecast News | 31 Jul |
| ReNeuron Group inks research evaluation deal with US firm Sharecast News | 25 Jun |
| Investor presentations | 25-Feb-21 07:02 |
|---|---|
| Appointment of Joint Broker | 25-Feb-21 07:00 |
| Director/PDMR Interest in Shares and Share Options | 12-Feb-21 22:40 |
| Total Voting Rights | 01-Feb-21 09:57 |
| Second Price Monitoring Extn | 18-Jan-21 09:01 |